Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.
Trending
- Grail and Quest Diagnostics to offer Galleri test to US physicians (Medical Device Network)
- Why 1 GI prefers working in an academic medical center (Becker’s GI & Endoscopy)
- Adenomas Linked to Greater Risk of Colorectal Cancer, All-Cause Mortality (HCP Live)
- Stool DNA testing ‘can be performed safely’ regardless of anticoagulant, antiplatelet use (Healio)
- Physician Practice Private Equity Transactions – A Refresher (JD Supra)
- ‘Gut-on-a-chip’ promises breakthroughs in health research (National University of Singapore)
- Considerations for Prescribing GLP-1s Get More Complicated (Medscape)
- The Doctor Will See You… On Amazon: Tech Giant Expands Plans to Merge Medicine with Marketplace (PYMNTS)